Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 23K | Jun 14, 2024 | Direct | ||
Kymera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 18, 2024 | Direct | ||
Rain Oncology Inc. | Director | Stock Option (Right to Buy) | 0 | Jan 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KYMR | Kymera Therapeutics, Inc. | Jun 18, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
RAIN | Rain Oncology Inc. | Jan 26, 2024 | 2 | $0 | 4 | Jan 26, 2024 | Director |
RAIN | Rain Oncology Inc. | Aug 9, 2023 | 1 | $0 | 4 | Aug 11, 2023 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
KYMR | Kymera Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Jun 17, 2022 | 1 | $0 | 4/A | Jun 27, 2022 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
KYMR | Kymera Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
RAIN | Rain Therapeutics Inc. | Jun 1, 2022 | 1 | $0 | 4 | Aug 19, 2022 | Director |
KYMR | Kymera Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |